Rezolute (RZLT) Share-based Compensation (2010 - 2026)
Rezolute (RZLT) reported Share-based Compensation of $4.4 million for Q1 2026, up 132.02% on a YoY basis from $1.9 million in Q1 2025, and up 29.58% sequentially from $3.4 million in Q4 2025.
Rezolute (RZLT) Share-based Compensation (2010 - 2026) Analysis & Trends
Rezolute (RZLT) has 16 years of Share-based Compensation data on file, last reported at $4.4 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 132.02% year-over-year to $4.4 million; the trailing twelve-month figure through Mar 2026 stood at $12.1 million (up 2.97% YoY), and the FY2025 full-year result was $18.7 million, up 61.21% from the prior year.
- Share-based Compensation grew to $4.4 million in Q1 2026, from $3.4 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $16.2 million in Q3 2025 to a low of -$3.3 million in Q2 2023.
- A 5-year average of $2.8 million and a median of $1.9 million in 2023 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation slumped 3361.0% in 2023 and jumped 1057.14% in 2025, its largest moves.
- Tracing RZLT's Share-based Compensation over 5 years: stood at $1.7 million in 2022, then climbed by 6.12% to $1.8 million in 2023, then fell by 21.34% to $1.4 million in 2024, then jumped by 136.06% to $3.4 million in 2025, then gained by 29.58% to $4.4 million in 2026.
- Business Quant data shows RZLT's Share-based Compensation at $4.4 million in Q1 2026, $3.4 million in Q4 2025, and $16.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - | 4.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.42 Mn |
| Mar 31, 2026 | 4.42 Mn |
| Dec 31, 2025 | 3.41 Mn |
| Dec 31, 2025 | 3.41 Mn |
| Sep 30, 2025 | 16.20 Mn |
| Sep 30, 2025 | 16.20 Mn |
| Jun 30, 2025 | 2.37 Mn |
| Jun 30, 2025 | 2.37 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 7.01 Mn |
| Jun 30, 2024 | 7.01 Mn |
| Mar 31, 2024 | 1.90 Mn |
| Mar 31, 2024 | 1.90 Mn |
| Dec 31, 2023 | 1.84 Mn |
| Dec 31, 2023 | 1.84 Mn |